International Biotechnology Trust (IBT)
Category Sector Equity Biotechnology
This investment trust can be held in an Investment ISA, SIPP and Investment Account
Sell
636.00p
Buy
642.00p
2.00p (+0.31%)
Discount/Premium
-9.98%
Estimated NAV
710.929p
Prices updated at 08 May 2024, 17:15 BST
| Prices minimum 15 mins delay
Prices in GBX
Investment objective
The objective is to achieve long term capital growth by investing in high growth, development stage biotechnology companies that are either quoted or unquoted. The company invests in companies that are considered to be good value with experienced management and strong potential upside through the development and/or commercialisation of a product, device or enabling technology.
Important documents: Please ensure that you have read the Key Information Document/Technical Guide
, Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and the fund information documents. These can be found within the Charges & documents section.
- Key stats
- Price
- Performance
- Charges & documents
- Shares & trades
- Dividends
- Portfolio
- Risk
- News & dates
- Trust info
- Director info
Most recent dividend payment
| 0.139 | |
| Cash Dividend | |
| 21 Dec 2023 | |
| 12 Dec 2023 | |
| 22 Dec 2023 | |
| 26 Jan 2024 | |
| Dividend cover | - |
Income only yield
No data available
Dividend per share
Income only yield data table
| Year | Income only yield |
|---|---|
| 2023 | - |
| 2022 | - |
| 2021 | - |
| 2020 | - |
| 2019 | - |
| 2018 | - |
| 2017 | - |
Dividend per share data table
| Year | Dividend per share |
|---|---|
| 2023 | 0.2810 |
| 2022 | 0.2970 |
| 2021 | 0.2990 |
| 2020 | 0.2660 |
| 2019 | 0.2640 |
| 2018 | 0.4100 |
| 2017 | 0.2300 |
